ICD-10 Code C88.31 | Immunoproliferative small intestinal disease, in remission Symptoms, Diagnosis, Billing

Immunoproliferative small intestinal disease, in remission is characterized by abnormal proliferation of immune cells in the small intestine, often associated with malabsorption and gastrointestinal symptoms. Accurate coding with ICD-10 Code C88.31 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.

What is ICD-10 Code C88.31 for Immunoproliferative small intestinal disease, in remission?

ICD-10 Code C88.31 represents Immunoproliferative small intestinal disease, in remission, a condition where abnormal immune cell growth in the small intestine has stabilized. This code is used when documenting patients who have shown improvement or resolution of symptoms, facilitating accurate billing and clinical documentation.

ICD-10 Code C88.31 – Clinical Definition and Explanation of Immunoproliferative small intestinal disease, in remission

Immunoproliferative small intestinal disease, in remission, is caused by an abnormal immune response leading to the proliferation of lymphoid tissue in the small intestine. It can progress to significant gastrointestinal complications if not monitored and treated appropriately. Medical attention is crucial to manage symptoms and prevent recurrence.

Key Clinical Features:

• Chronic diarrhea or malabsorption symptoms
• Weight loss and nutritional deficiencies
• Abdominal pain or discomfort
• Potential for lymphoma development

ICD-10 Code C88.31 for Immunoproliferative small intestinal disease, in remission – SOAP Notes & Clinical Use

ICD-10 Code C88.31 is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C88.31 for Immunoproliferative small intestinal disease, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C88.31 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C88.31 – Immunoproliferative small intestinal disease, in remission

Management of Immunoproliferative small intestinal disease, in remission, may require hospitalization for monitoring and treatment adjustments.

Antibiotic Therapy:

• First-line: Doxycycline 100 mg orally twice daily for 10-14 days
• Alternative: Metronidazole 500 mg orally three times daily for 7-10 days
• Consideration of prophylactic antibiotics in high-risk patients

Supportive Care:

• Nutritional support and dietary modifications
• Management of dehydration and electrolyte imbalances
• Regular monitoring of symptoms and laboratory parameters

Infection Control:

• Strict hand hygiene practices
• Isolation precautions if infectious complications arise
• Education on preventing transmission during outbreaks

How to Document Symptoms of Immunoproliferative small intestinal disease, in remission (ICD-10 C88.31) in SOAP Notes

Subjective:

• Patient reports intermittent abdominal pain and diarrhea.
• History of weight loss and nutritional deficiencies noted.
• Denies fever or recent infections.

Objective:

• Vital signs stable; weight loss of 5 kg since last visit.
• Abdominal examination reveals tenderness in the lower quadrants.
• Laboratory tests show normal electrolyte levels.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Immunoproliferative small intestinal disease, in remission (ICD-10 Code C88.31)

Assessment:

• Diagnosis: Immunoproliferative small intestinal disease, in remission.
• ICD-10 Code: C88.31.
• Contributing factors: Previous malabsorption and dietary non-compliance.

Plan:

• Continue monitoring nutritional status and adjust diet as needed.
• Consider follow-up imaging to assess intestinal health.
• Schedule follow-up appointment in 3 months.

Treatment & Plan Section for ICD-10 Code C88.31 – Immunoproliferative small intestinal disease, in remission

• Pharmacologic treatments may include immunosuppressants if indicated.
• Education on dietary management and symptom monitoring.
• Regular follow-up appointments to assess remission status.
• Consider referral to a dietitian for nutritional counseling.

Using ICD-10 Code C88.31 for Immunoproliferative small intestinal disease, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and treatment plans.
• Use C88.31 in conjunction with relevant procedure codes for billing.
• Maintain clear records of patient progress and response to treatment.
• Align treatment plans with clinical guidelines to support billing.

Related ICD-10 Codes Often Used with Immunoproliferative small intestinal disease, in remission

ICD-10 Code C88.31 in Medical Billing and Insurance for Immunoproliferative small intestinal disease, in remission

ICD-10 Code C88.31 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and treatment details.
• Use C88.31 in appropriate clinical contexts to support claims.
• Ensure compliance with payer-specific documentation requirements.

Common CPT Pairings: